Cytoreductive Surgery with the PlasmaJet Improved Quality-of-Life for Advanced Stage Ovarian Cancer Patients.
Gatske Nieuwenhuyzen-de BoerHanane AamranCaroline B van den BergSten WillemsenJurgen M J PiekNathalie Reesink-PetersMarianne MaliepaardH Lena C van DoornSuzanne PolinderHeleen van BeekhuizenPublished in: Cancers (2023)
This study demonstrated knowledge of patients' quality-of-life until two years after cytoreductive surgery. The use of the PlasmaJet Surgical device during cytoreductive surgery leads to a higher quality-of-life than conventional surgery with electrocoagulation alone. Even after adjustment for the mediator of surgical outcome, a higher quality-of-life was seen in patients who had surgery with the use of the PlasmaJet device.